A protein helps brain tumors hide from the immune system
Original title: Crosstalk Between CTSB+ Glioblastoma Cells and S100A10+ Macrophages: A Self-Reinforcing Circuit Promotes Immune Evasion and Limits Response to Immunotherapy.
How far along is this research?
- Lab cells
- Animals
- Review
- Tested in people
This was done in animals, not people. Most findings at this stage never become treatments.
This was only done in lab dishes and in mice.
The short version
In mice, blocking one protein helped the immune system fight brain tumors.
What was studied. Researchers studied glioblastoma: The fastest-growing type of glioma (grade 4). Treatment usually starts soon after diagnosis: surgery first, then radiation and chemotherapy. See the glossary, a fast growing brain tumor. They grew tumor cells and immune cells together in the lab. They also tested mice that had brain tumors.
What they found. They found a protein called cathepsin B, or CTSB. Tumor cells and nearby immune cells kept feeding signals to each other. This loop helped the tumor grow, spread, and hide from the immune system. In mice, blocking CTSB brought more immune fighter cells into the tumor. It also worked better when paired with an immune therapy drug.
What this means, and what it doesn't
What it could mean: Immune therapy often does not work well for glioblastoma: The fastest-growing type of glioma (grade 4). Treatment usually starts soon after diagnosis: surgery first, then radiation and chemotherapy. See the glossary. This study points to one possible reason why. It gives scientists a new target to test. It does not change any treatment a patient can get today.
What it doesn't mean: This does not mean a new treatment is ready. The work was done in lab dishes and in mice. Mice are not people, and many mouse results do not hold up. No one has tested this in patients yet. It is not a cure, and it will not change your care now.
Source: PubMed, August 29, 2026 · Read the original
This plain-language summary was written by AI and published automatically after passing our automatic safety checks. How we write.